Browsing Category
JRS Pharma
Development of integrated continuous pharmaceutical technologies
Thesis findings
1. Acetylsalicylic acid (ASA) was synthesized in continuous flow reactors for the first time. Design of experiment studies were conducted in order to optimize the two synthetic steps: i.e. the acetylation of salicylic acid (SA) and the quenching of impurities. By applying the…
Read More...
Read More...
Self-Nanoemulsifying System Loaded with Sildenafil Citrate and Incorporated within Oral Lyophilized…
Sildenafil citrate is a drug used throughout the world primarily to treat erectile dysfunction. Several problems with the commercially available product decrease its efficacy, such as limited solubility, delayed onset of action, and low bioavailability with a large variability in the absorption…
Read More...
Read More...
Disintegrant Selection in Hydrophobic Tablet Formulations
The hydrophobicity of poorly soluble drugs can delay tablets disintegration. We probed here the influence of different disintegrants on the disintegration of challenging hydrophobic formulations. Tablets containing diluents, hydrogenated vegetable oil and either sodium starch glycolate (SSG),…
Read More...
Read More...
Process Design of Continuous Powder Blending Using Residence Time Distribution and Feeding Models
The present paper reports a thorough continuous powder blending process design of acetylsalicylic acid (ASA) and microcrystalline cellulose (MCC) based on the Process Analytical Technology (PAT) guideline. A NIR-based method was applied using multivariate data analysis to achieve in-line process…
Read More...
Read More...
Tableting of mini-tablets in comparison with conventionally sized tablets: A comparison of tableting…
Mini-tablets are solid dosage forms with increasing interest for pharmaceutical industry due to clinical and biopharmaceutical benefits. But technological aspects on mini-tableting are not fully investigated. Therefore, the impact of punch size and tableting pressure for industrially relevant…
Read More...
Read More...
Solubility and Stability Enhanced Oral Formulations for the Anti-Infective Corallopyronin A
Novel-antibiotics are urgently needed to combat an increase in morbidity and mortality due to resistant bacteria. The preclinical candidate corallopyronin A (CorA) is a potent antibiotic against Gram-positive and some Gram-negative pathogens for which a solid oral formulation was needed for further…
Read More...
Read More...
Towards better understanding of the influence of process parameters in roll compaction/ dry…
A key quality attribute for solid oral dosage forms is their hardness and ability to withstand breaking or grinding. If the product is to be manufactured continuously, it can be of interest to monitor the hardness of the material at different stages of manufacturing. Using the controlled process…
Read More...
Read More...
Data-smart machine learning methods for predicting composition-dependent Young’s modulus of…
The ability to predict mechanical properties of compacted powder blends of Active Pharmaceutical Ingredients (API) and excipients solely from component properties can reduce the amount of ‘trial-and-error’ involved in formulation design. Machine Learning (ML) can reduce model development time and…
Read More...
Read More...
Optimization of residence time distribution in RCDG and an assessment of its applicability in…
Knowledge of residence time is a critical aspect in developing control and material diversion strategies for continuous manufacturing processes in pharmaceutical manufacturing. Dry granulation is a promising continuous granulation technique as it is fast and economical. In this study, a step-change…
Read More...
Read More...
Rettenmaier Natural Fiber Manufacturing (Changzhou) Site In Jiangsu Province In Pr China Receives…
EXCiPACT Press Release, Brussels, 04 November 2020
EXCiPACT asbl is pleased to announce that the Rettenmaier Natural Fiber Manufacturing (Changzhou) site in Jiangsu Province, PR China has recently been awarded an EXCiPACT GMP Certificate from BV China, one of EXCIPACT’s internationally…
Read More...
Read More...